CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Capex Y/Y Annual
Regencell Bioscience Holdings Limited  (NASDAQ: RGC)
 

RGC's Capital Expenditures Growth by Quarter and Year

Regencell Bioscience Holdings Limited's Capital Expenditures results by quarter and year

Download as CSV




RGC Capital Expenditures (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 0.15 0.03 0.78 0.00
3rd Quarter September 0.00 0.00 0.00 0.00
2nd Quarter June 0.00 0.00 0.00 0.00
1st Quarter March 0.00 0.00 0.00 0.00
FY   0.15 0.03 0.78 0.00

RGCs Annual Capital Expenditures
Regencell Bioscience Holdings Limited's Capital Expenditures in the fiscal year 2025 $ 0.15 millions
Regencell Bioscience Holdings Limited's Capital Expenditures in the fiscal year 2023 $ 0.03 millions
Regencell Bioscience Holdings Limited's Capital Expenditures in the fiscal year 2022 $ 0.00 millions
Regencell Bioscience Holdings Limited's Capital Expenditures in the fiscal year 2021 $ 0.00 millions
Regencell Bioscience Holdings Limited's Capital Expenditures in the fiscal year 2017 $ 250.40 millions




RGC Capital Expenditures fourth quarter 2025 Y/Y Growth Comment
Regencell Bioscience Holdings Limited achieved in the fourth quarter 2025, above Company average Capital Expenditures surge of 408.96% year on year, to $ 0.15 millions.

According to the results reported in the fourth quarter 2025, Regencell Bioscience Holdings Limited achieved the best Capital Expenditures growth in Legal Cannabis industry. While Regencell Bioscience Holdings Limited' s Capital Expenditures doubling of 408.96% ranks overall at the positon no. 160 in the fourth quarter 2025.


RGC Capital Expenditures ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 408.96 % -96.15 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   408.96 % -96.15 % - -

Financial Statements
Regencell Bioscience Holdings Limited's fourth quarter 2025 Capital Expenditures $ 0.15 millions RGC's Income Statement
Regencell Bioscience Holdings Limited's fourth quarter 2024 Capital Expenditures $ 0.03 millions Quarterly RGC's Income Statement


RGC Capital Expenditures (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   408.96 % -96.15 % - -


Suppliers by RGC Divisions >> Back to RGC Growth rate Comparisons >>


Capital Expenditures fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #1
Consumer Non Cyclical Sector #7
Overall #160

Capital Expenditures Y/Y Growth Statistics
High Average Low
99.09 % 23.6 % -96.49 %
 
Capital Expenditures fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #1
Consumer Non Cyclical Sector #7
Overall #160
Capital Expenditures Y/Y Growth Statistics
High Average Low
99.09 % 23.6 % -96.49 %
 

Capital Expenditures by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Regencell Bioscience Holdings Limited's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RGC's IV. Quarter Q/Q Capital Expenditures Comment


Regencell Bioscience Holdings Limited's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2025)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
0		 12 Months Ending
0		 12 Months Ending
0
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #


Cumulative Capital Expenditures growth Comment
In the Jun 30 2025 period, Regencell Bioscience Holdings Limited's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Jun 30 2025 period, Regencell Bioscience Holdings Limited's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Regencell Bioscience Holdings Limited achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Legal Cannabis Industry #
Consumer Non Cyclical Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Legal Cannabis Industry Capital Expenditures Growth Trends and Statistics
Consumer Non Cyclical Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
RGC's Capital Expenditures Growth Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth




Companies with similar Capital Expenditures doubling for the quarter ending Jun 30 2025 within Consumer Non Cyclical SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2025


About Regencell Bioscience Holdings Limited Capital Expenditures Growth Rates (RGC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.